AUGMENTATION STRATEGIES FOR TREATMENT‐RESISTANT ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META‐ANALYSIS. Issue 8 (12th May 2016)

• Record Type: Journal Article
• Authors: Patterson, Beth; Van Ameringen, Michael
• Is Part Of: Depression and anxiety. Volume 33:Issue 8(2016)
• Page Start: 728
• Page End: 736
• Publication Date: 2016-05-12
• Subjects: treatment resistance -- anxiety/anxiety disorders -- clinical trials -- pharmacotherapy -- antidepressants -- GAD/generalized anxiety disorder -- SAD/social anxiety disorder/social phobia -- panic attacks/agoraphobia; Anxiety -- Periodicals; Depression, Mental -- Periodicals; Depression -- Periodicals; Anxiety -- Periodicals; Anxiety Disorders -- Periodicals; 616.8527005
• DOI: 10.1002/da.22525
• Languages: English
• ISSNs: 1091-4269

Abstract

Abstract : Background: A systematic review and meta‐analysis was conducted to explore the efficacy of medication augmentation strategies compared to control treatments in patients who have had a partial or no response to initial treatment for generalized anxiety disorder, social anxiety disorder, and panic disorder. Methods: Double‐blind controlled trials of medication augmentation in adult treatment‐resistant anxiety disorders conducted between January 1990 and January 2015 were systematically reviewed and evaluated by two independent raters. The search identified 625 articles; 610 were excluded following abstract review and 15 had full‐text screening. Studies had to include a definition of treatment resistance, exclude concomitant medications, and have a parallel or crossover design. Data extraction forms were completed in duplicate. Results: Six studies were included in the meta‐analysis. Effect estimates were calculated using random effects modeling; heterogeneity was assessed and subgroup and sensitivity analyses were completed. Primary outcome was response, defined by Clinical Global Impression–Improvement score of ≤2. Augmentation was not associated with an increased risk of response, as compared with placebo ( RR = 1.08, 95% CI = 0.94–1.24). A small significant effect was found in reduction in symptom severity: standard mean difference = –0.32, 95% CI = –0.56 to –0.08. No significant differences between augmentation with medication versus placebo were found in ratings of functional impairment and dropouts due to adverse events. Conclusions: Augmentation does not appear to be beneficial in treatment‐resistant anxiety disorders. These results may be limited by small study samples, and a small number of overall studies in the analysis.